Tanhaji, Hajina A.

HRN: 14-25-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
METRONIDAZOLE 500MG (TAB)
04/01/2024
04/07/2024
PO
750mg
TID
Amoebiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: